APC基因的突变足以促使早期结直肠腺瘤生长。
APC mutations are sufficient for the growth of early colorectal adenomas.
作者信息
Lamlum H, Papadopoulou A, Ilyas M, Rowan A, Gillet C, Hanby A, Talbot I, Bodmer W, Tomlinson I
机构信息
Molecular and Population Genetics Laboratory, Imperial Cancer Research Fund, 44, Lincoln's Inn Fields, London WC2A 3PX, United Kingdom.
出版信息
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2225-8. doi: 10.1073/pnas.040564697.
It is not clear whether APC mutations are sufficient for early colorectal adenomas to grow or whether additional mutations at other loci are required. We previously have screened 210 early colorectal adenomas from familial adenomatous polyposis patients for mutations and allelic loss at APC. Here, we determined whether allelic loss at APC had any effect on the nearby alpha-catenin gene. However, loss on 5q in familial adenomatous polyposis adenomas rarely extended as far as alpha-catenin, and no differences in alpha-catenin protein expression were found in tumors that showed loss encompassing both APC and alpha-catenin. We then screened all 210 tumors for mutations at candidate loci other than APC (K-ras, beta-catenin, and allelic loss at 1p33-p35 and 1p36) and for microsatellite instability (MSI). Each of these loci has been implicated previously in early colorectal tumorigenesis. One tumor harbored a beta-catenin mutation and another MSI, but none showed K-ras mutation or allelic loss at 1p33-p35 or 1p36. These data support the following hypotheses derived from sporadic colorectal tumors: beta-catenin mutations are generally an alternative to mutations at APC, MSI is not usually an early phenomenon in colorectal tumorigenesis, and K-ras mutations are more typical of large- and moderate-sized adenomas. Contrary to some previous reports, chromosome 1p allelic loss is infrequent in very early adenomas. APC mutations are generally sufficient for colorectal tumors to grow to about 1-cm diameter, although chance mutations at other loci can provide these early colorectal adenomas with a selective advantage, and some colorectal tumors may develop along a pathway not involving APC.
APC突变对于早期结直肠腺瘤的生长是否足够,或者是否需要其他位点的额外突变尚不清楚。我们之前对210例家族性腺瘤性息肉病患者的早期结直肠腺瘤进行了APC突变及等位基因缺失的筛查。在此,我们确定APC等位基因缺失是否对附近的α-连环蛋白基因有任何影响。然而,家族性腺瘤性息肉病腺瘤中5q的缺失很少延伸至α-连环蛋白,并且在显示同时包含APC和α-连环蛋白缺失的肿瘤中未发现α-连环蛋白蛋白表达的差异。然后我们对所有210个肿瘤进行了APC以外候选位点(K-ras、β-连环蛋白以及1p33-p35和1p36处的等位基因缺失)的突变筛查以及微卫星不稳定性(MSI)检测。这些位点中的每一个之前都与早期结直肠肿瘤发生有关。一个肿瘤存在β-连环蛋白突变,另一个存在MSI,但均未显示K-ras突变或1p33-p35或1p36处的等位基因缺失。这些数据支持了源自散发性结直肠肿瘤的以下假说:β-连环蛋白突变通常是APC突变的替代方式,MSI在结直肠肿瘤发生中通常不是早期现象,并且K-ras突变在大、中型腺瘤中更典型。与一些先前的报道相反,在非常早期的腺瘤中1号染色体等位基因缺失很少见。APC突变通常足以使结直肠肿瘤生长至约1厘米直径,尽管其他位点的偶然突变可为这些早期结直肠腺瘤提供选择性优势,并且一些结直肠肿瘤可能沿着不涉及APC的途径发展。